<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">248063</article-id><article-id pub-id-type="doi">10.18565/aig.2017.12.68-77</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The transcriptional profile of cumulus cells in women with diminished ovarian reserve in ovarian stimulation protocols in different phases of the menstrual cycle in in vitro fertilization programs</article-title><trans-title-group xml:lang="ru"><trans-title>Транскрипционный профиль в клетках кумулюса у женщин со сниженным овариальным резервом в протоколах стимуляции функции яичников в различные фазы менструального цикла в программах экстракорпорального оплодотворения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bogatyreva</surname><given-names>Kh. A</given-names></name><name xml:lang="ru"><surname>Богатырева</surname><given-names>Хава Алиевна</given-names></name></name-alternatives><bio xml:lang="en"><p>postgraduate of 1st gynecology department</p></bio><bio xml:lang="ru"><p>аспирант 1-го гинекологического отделения</p></bio><email>bogatyreva-khava@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mishieva</surname><given-names>N. G</given-names></name><name xml:lang="ru"><surname>Мишиева</surname><given-names>Нона Годовна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, MD, Senior researcher of 11st gynecology department</p></bio><bio xml:lang="ru"><p>д.м.н., ведущий научный сотрудник 1-го гинекологического отделения</p></bio><email>nondoc555@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Burmenskaya</surname><given-names>O. V</given-names></name><name xml:lang="ru"><surname>Бурменская</surname><given-names>Ольга Владимировна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD., D.Sc., Senior Researsher of molecular-genetics Department</p></bio><bio xml:lang="ru"><p>д.б.н., старший научный сотрудник лаборатории молекулярно-генетических методов</p></bio><email>o_bourmenskaya@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Trofimov</surname><given-names>D. Yu.</given-names></name><name xml:lang="ru"><surname>Трофимов</surname><given-names>Дмитрий Юрьевич</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, D.Sc., professor, Head of molecular-genetics Department</p></bio><bio xml:lang="ru"><p>д.б.н., профессор, руководитель отдела клинической и молекулярной генетики</p></bio><email>d_trofimov@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Martazanova</surname><given-names>B. A</given-names></name><name xml:lang="ru"><surname>Мартазанова</surname><given-names>Белла Арсамаковна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Junior Researcher of 1st gynecology department</p></bio><bio xml:lang="ru"><p>к.м.н., младший научный сотрудник 1-го гинекологического отделения</p></bio><email>bellamart88@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lapina</surname><given-names>V. S</given-names></name><name xml:lang="ru"><surname>Лапина</surname><given-names>Вера Сергеевна</given-names></name></name-alternatives><bio xml:lang="en"><p>postgraduate of 1st gynecology department</p></bio><bio xml:lang="ru"><p>аспирант 1-го гинекологического отделения</p></bio><email>tifaniwow@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korolkova</surname><given-names>A. I</given-names></name><name xml:lang="ru"><surname>Королькова</surname><given-names>Анна Игоревна</given-names></name></name-alternatives><bio xml:lang="en"><p>graduate student of 1-st gynecology department</p></bio><bio xml:lang="ru"><p>аспирант I года обучения 1-го гинекологического отделения</p></bio><email>zaikinaai@icloud.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Martynova</surname><given-names>M. V</given-names></name><name xml:lang="ru"><surname>Мартынова</surname><given-names>Мария Валерьевна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, doctor of 1-st gynecology department</p></bio><bio xml:lang="ru"><p>врач 1-го гинекологического отделения</p></bio><email>martinova_m@bk.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Abubakirov</surname><given-names>A. N</given-names></name><name xml:lang="ru"><surname>Абубакиров</surname><given-names>Айдар Назимович</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Head of 1st gynecology department</p></bio><bio xml:lang="ru"><p>к.м.н., руководитель 1-го гинекологического отделения</p></bio><email>nondoc555@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ НЦАГиП им. академика В.И. Кулакова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2017</year></pub-date><issue>12</issue><issue-title xml:lang="en">NO12 (2017)</issue-title><issue-title xml:lang="ru">№12 (2017)</issue-title><fpage>68</fpage><lpage>77</lpage><history><date date-type="received" iso-8601-date="2023-02-18"><day>18</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, ООО «Бионика Медиа»</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/248063">https://journals.eco-vector.com/0300-9092/article/view/248063</self-uri><abstract xml:lang="en"><p>Objective. To explore the possibility of using the transcriptional prof ile in the cumulus cells to predict embryo quality in women with diminished ovarian reserve in the superovulation protocols in the follicular and luteal phases of the menstrual cycle. Materials and methods. 160 cumulus cell samples from 40 patients with diminished ovarian reserve, who underwent an in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) program, were analyzed during this investigation. The retrieved oocyte-cumulus complexes were divided into 2groups according to the treatment protocol phase. Group 1 (17 women; 70 samples) included oocytes obtained by IVF/ICSI procedures in the follicular phase of the cycle; Group 2 (23 women; 90 samples) comprised oocytes retrieved via IVF/ICSI during the luteal phase of the cycle. To identify the relationship between the expression levels of mRNA genes and the indicators of embryo quality in women with reduced ovarian reserve in the IVF/ICSI programs, the obtained cumulus cells were divided into three classes based on the quality of embryos according to the morphology assessment criteria: 1) good-quality embryos (n = 42); 2) satisfactory-quality embryos (n = 43); 3) poor-quality embryos (n = 17). A real-time RT-PCR assay was used to estimate cumulus cell mRNA expression for 10 genes: HAS2, PTGS2, GREM1, VCAN, ITPKA, ALCAM(CD166), SDC4, CALM2, SPSB, and TP53I3. Results. Analysis of embryological indicators revealed no statistically significant differences. The mean number of oocytes retrieved on the day of transvaginal puncture was 3.6±1.9 and 4.2±2.0 in the follicular and luteal phase stimulation groups, respectively (p &gt; 0.05). The number of blastocysts was 1.6±1.4 and 1.9±1.8, respectively (p &gt; 0.05). The cumulus cells of good-quality embryos displayed an increase in the mRNA expression levels for the HAS2, VCAN, and PTGS2 genes by 1.8, 2.0, and 2.9 times, respectively; and a decrease in that for the ITPKA gene by 1.9 times (p &lt; 0.05). The logistic regression model was proposed to predict embryo quality in women with diminished ovarian reserve, which took into account mRNA expression levels for the VCAN, HAS2, and PTGS2 genes (the sensitivity and specificity of the technique were 90.5 and 70.6%, respectively). The mRNA expression level for the VCAN gene is the most important marker of embryo quality according to the morphology assessment criteria in the IVF/ICSI program. There was a statistically significant increase in the cumulus cell mRNA expression levels for the VCAN, SDC4, and TP53I3 genes in Study Group 2 (p = 0.003, p = 0.005, and p &lt; 0.001, respectively). Conclusion. The mRNA expression levels for the VCAN, HAS2, and PTGS2 genes may be used as predictors for the good quality of developing embryos in women with diminished ovarian reserve. Superovulation induction during the luteal phase of the menstrual cycle has no negative impact on the developmental potential of oocytes and the quality of obtained embryos.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Изучить возможность использования транскрипционного профиля в клетках кумулюса для прогноза качества эмбрионов у женщин со сниженным овариальным резервом в протоколах стимуляции суперовуляции в фолликулярную и лютеиновую фазы менструального цикла. Материал и методы. Проанализированы 160 образцов кумулюсных клеток от 40 пациенток со сниженным овариальным резервом, проходивших программу экстракорпорального оплодотворения/ интрацитоплазматической инъекции сперматозоида (ЭКО/ИКСИ). Полученные ооцит-кумулюсные комплексы разделялись на 2 группы в зависимости от фазы проведенного протокола лечения I группа (17 женщин - 70 образцов) ооциты, полученные в фолликулярной фазе цикла, II группа (23 женщины - 90 образцов) - ооциты, полученные в лютеиновой фазе цикла. Полученные кумулюсные клетки были разделены на три класса в зависимости от качества эмбрионов согласно морфологическим критериям оценки: 1-й класс - эмбрионы хорошего качества (n=42), 2-й класс - эмбрионы удовлетворительного качества (n=43), 3-й класс - эмбрионы неудовлетворительного качества (n=17). Был исследован уровень экспрессии мРНК 10 генов в кумулюсных клетках методом ОТ-ПЦР в режиме реального времени: HAS2, PTGS2, GREM1, VCAN, ITPKA, ALCAM (CD166), SDC4, CALM2, SPSB2 и TP53I3. Результаты. При анализе эмбриологических показателей статистически значимых различий выявлено не было. Среднее число полученных ооцитов составило 3,6±1,9 в группе стимуляции в фолликулярной фазе, 4,2±2,0 в группе стимуляции в лютеиновой фазе (р&gt;0,05). Количество бластоцист составило 1,6±1,4 и 1,9±1,8 соответственно (р&gt;0,05). В кумулюсных клетках эмбрионов хорошего качества выявлено повышение уровня экспрессии мРНК генов H AS2 в 1,8 раза, VCAN в 2 раза и PTGS2 в 2,9 раза, и снижение уровня мРНК гена ITPKA в 1,9 раза (р&lt;0,05). Предложена логистическая регрессионная модель прогноза качества эмбрионов у женщин со сниженным овариальным резервом, учитывающая уровень экспрессии мРНК генов VCAN, HAS2 и PTGS2 (чувствительность и специфичность метода составили 90,5 и 70,6% соответственно). Уровень экспрессии мРНК гена VCAN является наиболее информативным маркером для оценки качества эмбрионов согласно морфологическим критериям оценки. Выявлено статистически значимое повышение уровня экспрессии мРНК генов VCAN, SDC4, и TP53I3 в клетках кумулюса во II группе исследования (р=0,003, p=0,005, p&lt;0,001 соответственно). Заключение. Уровни экспрессии мРНК генов VCAN, HAS2 и PTGS2 могут быть использованы как предикторы хорошего качества развивающихся эмбрионов у женщин со сниженным овариальным резервом. Индукция суперовуляции в лютеиновой фазе менструального цикла не оказывает отрицательного влияния на потенциал развития ооцитов и качество получаемых эмбрионов.</p></trans-abstract><kwd-group xml:lang="en"><kwd>infertility</kwd><kwd>ovarian stimulation</kwd><kwd>luteal phase</kwd><kwd>cumulus cells</kwd><kwd>mRNA gene expression</kwd><kwd>in vitro fertilization</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>бесплодие</kwd><kwd>стимуляция функции яичников</kwd><kwd>лютеиновая фаза</kwd><kwd>кумулюсные клетки</kwd><kwd>экспрессия мРНК генов</kwd><kwd>экстракорпоральное оплодотворение</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Краснопольская К.В., Калугина А.С. Феномен «бедного» ответа на стимуляторы суперовуляции в программах ЭКО. Проблемы репродукции. 2004; 1: 51-8. [Krasnopolskaya K.V., Kalugina A.S. The phenomenon of a “poor” response to stimulators of superovulation in IVF programs. Problemy reproduktsii. 2004; 1: 51-8. (in Russian)]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ubaldi F.M., Vaiarelli A., Alviggi C., Trabucco E., Zullo F., Capalbo A. et al. Double stimulation in a single menstrual cycle increases the number of oocytes retrieved in poor prognosis patients undergoing IVF treatment. Prospective study with historical control. Fertil. Steril. 2015; 104(3, Suppl.): e322. P-630.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Triantafyllidou O., Sigalos G., Vlahos N. Dehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders. Hum. Fertil. (Camb.). 2016; 7: 1-8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>de Mello Bianchi P.H., Serafini P., Monteiro da Rocha A., Assad Hassun P., Alves da Motta E.L., Sampaio Baruselli P., Chada Baracat E. Review: follicular waves in the human ovary: a new physiological paradigm for novel ovarian stimulation protocols. Reprod. Sci. 2010; 17(12): 1067-76.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Kuang Y., Chen Q., Hong Q., Lyu Q., Ai A., Fu Y., Shoham Z. Double stimulations during the follicular and luteal phases of poor responders in IVF/ ICSI programmes (Shanghai protocol). Reprod. Biomed. Online. 2014; 29(6): 684-91.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ebner T., Moser M., Sommergruber M., Tews G. Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review. Hum. Reprod. Update. 2003; 9(3): 251-62.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Alfarawati S., Fragouli E., Colls P., Stevens J., Gutiérrez-Mateo C., Schoolcraft W.B. et al. The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil. Steril. 2011; 95(2): 520-4.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>McKenzie L.J., Pangas S.A., Carson S.A., Kovanci E., Cisneros P., Buster J.E. et al. Human cumulus granulosa cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF. Hum. Reprod. 2004; 19(12): 2869-74.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Assou S., Haouzi D., Mahmoud K., Aouacheria A., Guillemin Y., Pantesco V. et al. A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study. Mol. Hum. Reprod. 2008; 14(12): 711-9.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hamel M., Dufort I., Robert C., Leveille M.C., Leader A., Sirard M.A. Genomic assessment of follicular marker genes as pregnancy predictors for human IVF. Mol. Hum. Reprod. 2010; 16: 87-96.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hamel M., Dufort I., Robert C., Gravel C., Leveille M.C., Leader A., Sirard M.A. Identification of differentially expressed markers in human follicular cells associated with competent oocytes. Hum. Reprod. 2008; 23(5): 1118-27.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Moley K.H., Schreiber J.R. Ovarian follicular growth, ovulation and atresia. Endocrine, paracrine and autocrine regulation. Adv. Exp. Med. Biol. 1995; 377: 103-19.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Gilchrist R.B., Lane M., Thompson J.G. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum. Reprod. Update. 2008; 14(2): 159-77.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Tanghe S., Van Soom A., Nauwynck H., Coryn M., de Kruif A. Minireview: Functions of the cumulus oophorus during oocyte maturation, ovulation, and fertilization. Mol. Reprod. Dev. 2002; 61(3): 414-24.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Albertini D.F., Combelles C.M., Benecchi E., Carabatsos M.J. Cellular basis for paracrine regulation of ovarian follicle development Reproduction. 2001; 121(5): 647-53.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Блашкив Т.В., Шепель А.А., Вознесенская Т.Ю. Экспрессия генов клетками кумулюсного окружения ооцита в период овуляции и оплодотворения (обзор литературы). Проблемы репродукции. 2014; 1: 55-8. [Blashkov T.V., Shepel A.A., Voznesenskaya T.Yu. Expression of genes by cells of cumulus surrounding oocyte during ovulation and fertilization (literature review). Problemy reproduktsii. 2014; 1: 55-8. (in Russian)]</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Anderson R.A., Sciorio R., Kinnell H., Bayne R.A., Thong K.J., de Sousa P.A., Pickering S. Cumulus gene expression as a predictor of human oocyte fertilisation, embryo development and competence to establish a pregnancy. Reproduction. 2009;138(4): 629-37.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Wathlet S., Adriaenssens T., Segers I., Verheyen G., Van de Velde H., Coucke W. et al. Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients. Hum. Reprod. 2011; 26(5): 1035-51.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Gebhardt K.M., Feil D.K., Dunning K.R., Lane M., Russell D.L. Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer. Fertil. Steril. 2011; 96(1): 47-52.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Wathlet S., Adriaenssens T., Segers I., Verheyen G., Janssens R., Coucke W. et al. New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. Fertil. Steril. 2012; 98(2): 432-9.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Сафронова Н.А., Калинина Е.А., Донников А.Е., Бурменская О.В., Макарова Н.П., Зобова А.В., Алиева К.У., Горшинова В.К. Трофимов Д.Ю., Сухих Г.Т. Ассоциация экспрессии генов в кумулюсных клетках с эмбриологическими показателями в программах вспомогательных репродуктивных технологий. Акушерство и гинекология. 2016; 7: 60-6. http:// dx.doi.org/10.18565/aig.2016.7.60-66</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Gardner D.K., Schoolcraft W.B. In vitro culture of human blastocysts. In: Jansen R., Mortimer D., eds. Toward reproductive certainty: fertility and genetics beyond. Carnforth: Parthenon Publishing; 1999: 378-88.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Sathyan S., Koshy L.V., Balan S., Easwer H.V., Premkumar S., Nair S. et al. Association of Versican (VCAN) gene polymorphisms rs251124 and rs2287926 (G428D), with intracranial aneurysm. Meta Gene. 2014; 2: 651-60.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Theocharis A.D. Versican in health and disease. Connect. Tissue Res. 2008; 49(3): 230-4.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>LaPierre D.P., Lee D.Y., Li S.Z., Xie Y.Z., Zhong L., Sheng W. et al. The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res. 2007; 67(10): 4742-50.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Bukong T.N., Maurice S.B., Chahal B., Schaeffer D.F., Winwood P.J. Versican: a novel modulator of hepatic fibrosis. Lab. Invest. 2016; 96(3): 361-74.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Xie J., Wang J., Li R., Dai Q., Yong Y., Zong B. et al. Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction. J. Mol. Cell. Cardiol. 2012; 53(2): 250-8.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Sutton A., Friand V., Brulé-Donneger S., Chaigneau T., Ziol M., Sainte-Catherine O. et al. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol. Cancer Res. 2007; 5(1): 21-33.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Sakata M., Kobayashi H., Sun G.W., Mochizuki O., Takagi A., Kojima T. Ryudocan expression by luteinized granulosa cells is associated with the process of follicle atresia. Fertil. Steril. 2000; 74(6): 1208-14.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Porté S., Valencia E., Yakovtseva E.A., Borràs E., Shafqat N., Debreczeny J.E. et al. Three-dimensional structure and enzymatic function of proapoptotic human p53-inducible quinone oxidoreductase PIG3. J. Biol. Chem. 2009; 284(25): 17194-205.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Lee J.H., Kang Y., Khare V., Jin Z.Y., Kang M.Y., Yoon Y. et al. The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene. 2010; 29(10): 1431-50.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Herraiz C., Calvo F., Pandya P., Cantelli G., Rodriguez-Hernandez I., Orgaz J.L. et al. Reactivation of p53 by a cytoskeletal sensor to control the balance between DNA damage and tumor dissemination. J. Natl. Cancer Inst. 2015;108(1): pii: djv289.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Fragouli E., Wells D., Iager A.E., Kayisli U.A., Patrizio P. Alteration of gene expression in human cumulus cells as a potential indicator of oocyte aneuploidy. Hum. Reprod. 2012; 27(8): 2559-68.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Marei W.F.A., Salavati M., Fouladi-Nashta A.A. Critical role of hyaluronidase-2 during preimplantation embryo development. Mol. Hum. Reprod. 2013; 19(9): 590-9.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Yokoo M., Sato E. Cumulus-oocyte complex interactions during oocyte maturation. Int. Rev. Cytol. 2004; 235: 251-91.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Itano N., Kimata K. Mammalian hyaluronan synthases. IUBMB Life. 2002; 54(4): 195-9.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Camenisch T.D., Spicer A.P., Brehm-Gibson T., Biesterfeldt J., Augustine M.L., Calabro A. Jr. et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 2000; 106(3): 349-60.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Hernandez-Gonzalez I., Gonzalez-Robayna I., Shimada M., Wayne C.M., Ochsner S.A., White L., Richards J.S. Gene expression profiles of cumulus cell oocyte complexes during ovulation reveal cumulus cells express neuronal and immune-related genes: does this expand their role in the ovulation process? Mol. Endocrinol. 2006; 20(6): 1300-21.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Shimada M., Yanai Y., Okazaki T., Noma N., Kawashima I., Mori T., Richards J.S. Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization. Development. 2008; 135(11): 2001-11.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Alaniz L., Rizzo M., Garcia M.G., Piccioni F., Aquino J.B., Malvicini M. et al. Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma. Cancer Immunol. Immunother. 2011; 60(10): 1383-95.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Ohno-Nakahara M., Honda K., Tanimoto K., Tanaka N., Doi T., Suzuki A. et al. Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes. J. Biochem. 2004; 135(5): 567-75.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Matsumoto K., Li Y., Jakuba C., Sugiyama Y., Sayo T., Okuno M. et al. Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb. Development. 2009; 136: 2825-35.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Arosh J.A., Banu S.K., Chapdelaine P., Fortier M.A. Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy. Endocrinology. 2004; 145(1): 407-17.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Davis B.J., Lennard D.E., Lee C.A., Tiano H.F., Morham S.G., Wetsel W.C., Langenbach R. Anovulation in cyclooxygenase-2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. Endocrinology. 1999; 140(6): 2685-95.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Lim H., Paria B.C., Das S.K., Dinchuk J.E., Langenbach R., Trzaskos J.M., Dey S.K. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 1997; 91(2): 197-208.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Adriaenssens T., Segers I., Wathlet S., Smitz J. The cumulus cell gene expression profile of oocytes with different nuclear maturity and potential for blastocyst formation. J. Assist. Reprod. Genet. 2011; 28(1): 31-40.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Cillo F., Brevini T.A., Antonini S., Paffoni A., Ragni G., Gandolfi F. Association between human oocyte developmental competence and expression levels of some cumulus genes. Reproduction. 2007; 134(5): 645-50.</mixed-citation></ref></ref-list></back></article>
